| |
|
HDV | Abstract Library |
 |
| |
| The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors. |
| 1. | Identifying barriers to hepatitis B and delta screening, prevention, and linkage to care among people who use drugs in Philadelphia, Pennsylvania, USA |
| |
Harm Reduct J. 2024 Nov 15;21(1):199. doi: 10.1186/s12954-024-01117-4.
Beatrice Zovich 1, Catherine Freeland 2, Holly Moore 2, Kara Sapp 2, Anousha Qureshi 2, Amy Jessop 3, Rachel Holbert 3, Fiona Borondy-Jenkins 2, Quinn Plunkett 2 4, Chari Cohen 2
|
|
| |
|
|
| |
| 3. | Reflex testing for anti-HDV in HBsAg-positive patients offers high diagnostic yield in a large Central European tertiary care center |
| |
Sci Rep. 2024 Oct 29;14(1):25921. doi: 10.1038/s41598-024-77737-4.
Johannes Bernhard 1, Michael Schwarz 1, Lorenz Balcar 1, Benedikt Hofer 1, Nina Dominik 1, Robert Strassl 2, Stephan Aberle 3, Petra Munda 1, Mattias Mandorfer 1, Michael Trauner 1, Thomas Reiberger 4, Mathias Jachs 5
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 7. | Triple burden of hepatitis B, hepatitis Delta viruses, and Plasmodium falciparum to pregnant women |
| |
IJID Reg. 2024 Sep 10:13:100447. doi: 10.1016/j.ijregi.2024.100447. eCollection 2024 Dec.
Aude Sandrine Andeme Eyi 1, Opheelia Makoyo Komba 2, Claire Chambellant 3, Ismaël Pierrick Mikelet Boussoukou 1, Lydie Moukambi 1, Khalilath Morènikè Woura Ajaho Moukambi 1, Enide Iroungou Boukani 1, Ofilia Mvoundza Ndjindji 1, Anicet Christel Maloupazoa Siawaya 1, Patrice Emery Itoudi Bignoumba 4, Isabelle Chemin 3, Joel Fleury Djoba Siawaya 1, Bénédicte Ndeboko 1 5
|
|
| |
|
|
| |
| 9. | Reflex testing for anti-HDV in HBsAg-positive patients offers high diagnostic yield in a large Central European tertiary care center |
| |
Sci Rep. 2024 Oct 29;14(1):25921. doi: 10.1038/s41598-024-77737-4.
Johannes Bernhard 1, Michael Schwarz 1, Lorenz Balcar 1, Benedikt Hofer 1, Nina Dominik 1, Robert Strassl 2, Stephan Aberle 3, Petra Munda 1, Mattias Mandorfer 1, Michael Trauner 1, Thomas Reiberger 4, Mathias Jachs 5
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 19. | Global hepatitis B and D community advisory board: expectations, challenges, and lessons learned |
| |
Front PublicHealth. 2024Aug26:12:1437502. doi:10.3389/fpubh.2024.1437502.eCollection 2024.
Fiona Borondy-Jenkins # 1, Bright Ansah 1, Jacki Chen 1, Amanda Goldring 1, Yasmin Ibrahim # 1, Shaibu Issa 1, Silvana Lesidrenska 1, Tanya Machado # 1, Holly Moore # 1, Richard Njouom 1, Prince Okinedo 1, Rhea Racho 1, Lori Scott 1, Beatrice Zovich # 1, Chari Cohen # 1
|
|
| |
|
|
| |
| 21. | High diagnostic value of transient elastography for advanced fibrosis and cirrhosis in patients with chronic hepatitis delta |
| |
ClinGastroenterolHepatol. 2024Aug27:S15423565(24)007766.doi:10.1016/j.cgh.2024.08.008. Online ahead of print.
Dominique Roulot 1, Ségolène Brichler 2, Richard Layese 3, Louis d'ALTEROCHE 4, Nathalie Ganne-Carrie 5, Christiane Stern 6, Antonio Saviano 7, Vincent Leroy 8, Françoise Roudot-Thoraval 3, Victor de Ledinghen 9; DELTAVIR study group
Collaborators
Véronique Loustaud-Ratti, Christine Silvain, Souad Benali, Patrick Ingiliz, Martial Gouton, Dominique Guyader, Bruno Roche, Olivier Chazouillères, Tarik Asselah, Marianne Ziol
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 25. | Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinoma |
| |
Liver Int. 2024 Jul;44(7):1588-1599. doi: 10.1111/liv.15855. Epub 2024 Mar 1.
Edoardo G Giannini 1 2, Andrea Pasta 1 2, Giulia Pieri 1 2, Maria Corina Plaz Torres 1 2, Mariarosaria Marseglia 3 4, Filippo Pelizzaro 5, Angelo Sangiovanni 6, Giuseppe Cabibbo 7, Giorgia Ghittoni 8, Mariella Di Marco 9, Francesco Giuseppe Foschi 10, Maria Guarino 11, Elisabetta Biasini 12, Carlo Saitta 13, Claudia Campani 14, Gianluca Svegliati-Baroni 15, Antonio Gasbarrini 16, Maurizia Rossana Brunetto 17, Donatella Magalotti 18, Francesco Azzaroli 19, Andrea Mega 20, Rodolfo Sacco 21, Gerardo Nardone 22, David Sacerdoti 23, Alberto Masotto 24, Gianpaolo Vidili 25, Laura Bucci 4 26, Alessandro Vitale 27, Franco Trevisani 4 26; Italian Liver Cancer (ITA.LI.CA) group
Collaborators
- Italian Liver Cancer (ITA.LI.CA) group:
Maurizio Biselli, Lorenzo Lani, Benedetta Stefanini, Valentina Santi, Alessandro Granito, Fabio Piscaglia, Francesco Tovoli, Luca Muratori, Francesca Benevento, Fabio Farinati, Gloria Allegrini, Calogero Cammà, Ciro Celsa, Paolo Giuffrida, Carmelo Marco Giacchetto, Gabriele Rancatore, Maria Vittoria Grassini, Roberta Ciccia, Alessandro Grova, Mauro Salvato, Valentina Adotti, Stefano Gitto, Fabio Marra, Martina Rosi, Vittoria Bevilacqua, Alberto Borghi, Fabio Conti, Anna Chiara Dall'Aglio, Giorgio Ercolani, Federica Mirici, Laura Schiadà, Chiara Scorzoni, Giulia Scandali, Francesca Romana Ponziani, Gabriele Missale, Andrea Olivani, Mario Capasso, Valentina Cossiga, Filomena Morisco, Ester Marina Cela, Antonio Facciorusso, Valentina Lauria, Giorgio Pelecca, Fabrizio Chegai, Fabio Coratella, Mariano Ortenzi, Serena Dell'Isola, Roberto Filomia, Concetta Pitrone, Giovanni Raimondo, Assunta Sauchella, Elton Dajti, Federico Ravaioli, Filippo Oliveri, Gabriele Ricco, Veronica Romagnoli, Alessandro Inno, Fabiana Marchetti, Pietro Coccoli, Antonio Malerba, Alberta Cappelli, Cristina Mosconi, Matteo Renzulli, Luca Marzi
|
|
| |
|
|
| |
| 27. | Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D |
| |
N Engl J Med. 2024 Jul 11;391(2):133-143. doi: 10.1056/NEJMoa2314134.Epub 2024 Jun 6.
Tarik Asselah 1, Vladimir Chulanov 1, Pietro Lampertico 1, Heiner Wedemeyer 1, Adrian Streinu-Cercel 1, Victor Pântea 1, Stefan Lazar 1, Gheorghe Placinta 1, George S Gherlan 1, Pavel Bogomolov 1, Tatyana Stepanova 1, Viacheslav Morozov 1, Vladimir Syutkin 1, Olga Sagalova 1, Dmitry Manuilov 1, Renee-Claude Mercier 1, Lei Ye 1, Ben L Da 1, Grace Chee 1, Audrey H Lau 1, Anu Osinusi 1, Marc Bourliere 1, Vlad Ratziu 1, Stanislas Pol 1, Marie-Noëlle Hilleret 1, Fabien Zoulim 1
|
|
| |
|
|
| |
| 29. | Treatment with bulevirtide in HIV-infected patients with chronic hepatitis D: ANRS HD EP01 BuleDelta and compassionate cohort |
| |
JHEP Rep. 2024 Mar 26;6(8):101057. doi: 10.1016/j.jhepr.2024.101057. eCollection 2024 Aug.
Victor de Lédinghen 1, Claire Fougerou-Leurent 2, Estelle Le Pabic 2, Stanislas Pol 3, Dulce Alfaiate 4, Karine Lacombe 5, Marie-Noëlle Hilleret 6, Caroline Lascoux-Combe 7, Anne Minello 8, Eric Billaud 9, Isabelle Rosa 10, Anne Gervais 11, Vlad Ratziu 12, Nathalie Ganne 13, Georges-Philippe Pageaux 14, Vincent Leroy 15, Véronique Loustaud-Ratti 16, Philippe Mathurin 17, Julie Chas 18, Caroline Jezequel 19, Sophie Métivier 20, Jérôme Dumortier 21, Jean-Pierre Arpurt 22, Tarik Asselah 23, Bruno Roche 24, Antonia Le Gruyer 25, Marc-Antoine Valantin 26, Caroline Scholtès 27, Emmanuel Gordien 28, Christelle Tual 2, Amel Kortebi 2, Fatoumata Coulibaly 29, Eric Rosenthal 29, Miroslava Subic-Levrero 30, Dominique Roulot 13, Fabien Zoulim 30; ANRS HD EP01 BuleDelta study group
Collaborators
ANRS HD EP01 BuleDelta study group:
François Raffi, Laurent Alric, Patrick Miailhes, Albert Tran, Christiane Stern, Xavier Causse, Simona Tripon, Ghassan Riachi, Olivier Chazouillères, Armando Abergel, Louis d'Alteroche, Jérôme Gournay, Garance Lagadic, Patrizia Carrieri, Ségolène Brichler, Martin Siguier, Jessica Krause, Juliette Foucher, Souad Ben Ali, Magdalena Meszaros, Anne Varaut, Valérie Canva
|
|
| |
| 30. | Patient-reported outcomes in chronic hepatitis delta: An exploratory analysis of the Phase III MYR301 trial of bulevirtide |
| |
J Hepatol. 2024 Jul 13:S0168-8278(24)02337-7. doi: 10.1016/j.jhep.2024.06.031.Online ahead of print.
Maria Buti 1, Heiner Wedemeyer 2, Soo Aleman 3, Vladimir Chulanov 4, Viacheslav Morozov 5, Olga Sagalova 6, Tatyana Stepanova 7, Robert G Gish 8, Andrew Lloyd 9, Ankita M Kaushik 10, Vithika Suri 10, Dmitry Manuilov 10, Anu O Osinusi 10, John F Flaherty 10, Pietro Lampertico 11
|
|
| |
| 31. | Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D |
| |
N Engl J Med. 2024 Jul 11;391(2):133-143. doi: 10.1056/NEJMoa2314134.Epub 2024 Jun 6.
Tarik Asselah 1, Vladimir Chulanov 1, Pietro Lampertico 1, Heiner Wedemeyer 1, Adrian Streinu-Cercel 1, Victor Pântea 1, Stefan Lazar 1, Gheorghe Placinta 1, George S Gherlan 1, Pavel Bogomolov 1, Tatyana Stepanova 1, Viacheslav Morozov 1, Vladimir Syutkin 1, Olga Sagalova 1, Dmitry Manuilov 1, Renee-Claude Mercier 1, Lei Ye 1, Ben L Da 1, Grace Chee 1, Audrey H Lau 1, Anu Osinusi 1, Marc Bourliere 1, Vlad Ratziu 1, Stanislas Pol 1, Marie-Noëlle Hilleret 1, Fabien Zoulim 1
|
|
| |
| 32. | Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinoma |
| |
Liver Int. 2024 Jul;44(7):1588-1599. doi: 10.1111/liv.15855. Epub 2024 Mar 1.
Edoardo G Giannini 1 2, Andrea Pasta 1 2, Giulia Pieri 1 2, Maria Corina Plaz Torres 1 2, Mariarosaria Marseglia 3 4, Filippo Pelizzaro 5, Angelo Sangiovanni 6, Giuseppe Cabibbo 7, Giorgia Ghittoni 8, Mariella Di Marco 9, Francesco Giuseppe Foschi 10, Maria Guarino 11, Elisabetta Biasini 12, Carlo Saitta 13, Claudia Campani 14, Gianluca Svegliati-Baroni 15, Antonio Gasbarrini 16, Maurizia Rossana Brunetto 17, Donatella Magalotti 18, Francesco Azzaroli 19, Andrea Mega 20, Rodolfo Sacco 21, Gerardo Nardone 22, David Sacerdoti 23, Alberto Masotto 24, Gianpaolo Vidili 25, Laura Bucci 4 26, Alessandro Vitale 27, Franco Trevisani 4 26; Italian Liver Cancer (ITA.LI.CA) group
Collaborators
Italian Liver Cancer (ITA.LI.CA) group:
Maurizio Biselli, Lorenzo Lani, Benedetta Stefanini, Valentina Santi, Alessandro Granito, Fabio Piscaglia, Francesco Tovoli, Luca Muratori, Francesca Benevento, Fabio Farinati, Gloria Allegrini, Calogero Cammà, Ciro Celsa, Paolo Giuffrida, Carmelo Marco Giacchetto, Gabriele Rancatore, Maria Vittoria Grassini, Roberta Ciccia, Alessandro Grova, Mauro Salvato, Valentina Adotti, Stefano Gitto, Fabio Marra, Martina Rosi, Vittoria Bevilacqua, Alberto Borghi, Fabio Conti, Anna Chiara Dall'Aglio, Giorgio Ercolani, Federica Mirici, Laura Schiadà, Chiara Scorzoni, Giulia Scandali, Francesca Romana Ponziani, Gabriele Missale, Andrea Olivani, Mario Capasso, Valentina Cossiga, Filomena Morisco, Ester Marina Cela, Antonio Facciorusso, Valentina Lauria, Giorgio Pelecca, Fabrizio Chegai, Fabio Coratella, Mariano Ortenzi, Serena Dell'Isola, Roberto Filomia, Concetta Pitrone, Giovanni Raimondo, Assunta Sauchella, Elton Dajti, Federico Ravaioli, Filippo Oliveri, Gabriele Ricco, Veronica Romagnoli, Alessandro Inno, Fabiana Marchetti, Pietro Coccoli, Antonio Malerba, Alberta Cappelli, Cristina Mosconi, Matteo Renzulli, Luca Marzi
|
|
| |
| 33. | Hepatitis C Virus as a Possible Helper Virus in Human Hepatitis Delta Virus Infection |
| |
Viruses. 2024 Jun 20;16(6):992. doi: 10.3390/v16060992.
Maria Grazia Crobu 1 2, Paolo Ravanini 1, Clotilde Impaloni 1, Claudia Martello 1, Olivia Bargiacchi 3, Christian Di Domenico 1, Giulia Faolotto 1, Paola Macaluso 1, Alessio Mercandino 1, Miriam Riggi 1, Vittorio Quaglia 1, Stefano Andreoni 1, Mario Pirisi 4, Carlo Smirne 4
|
|
| |
|
|
| |
| 35. | Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinoma |
| |
Liver Int. 2024 Jul;44(7):1588-1599. doi: 10.1111/liv.15855. Epub 2024 Mar 1.
Edoardo G Giannini 1 2, Andrea Pasta 1 2, Giulia Pieri 1 2, Maria Corina Plaz Torres 1 2, Mariarosaria Marseglia 3 4, Filippo Pelizzaro 5, Angelo Sangiovanni 6, Giuseppe Cabibbo 7, Giorgia Ghittoni 8, Mariella Di Marco 9, Francesco Giuseppe Foschi 10, Maria Guarino 11, Elisabetta Biasini 12, Carlo Saitta 13, Claudia Campani 14, Gianluca Svegliati-Baroni 15, Antonio Gasbarrini 16, Maurizia Rossana Brunetto 17, Donatella Magalotti 18, Francesco Azzaroli 19, Andrea Mega 20, Rodolfo Sacco 21, Gerardo Nardone 22, David Sacerdoti 23, Alberto Masotto 24, Gianpaolo Vidili 25, Laura Bucci 4 26, Alessandro Vitale 27, Franco Trevisani 4 26; Italian Liver Cancer (ITA.LI.CA) group
Collaborators
Italian Liver Cancer (ITA.LI.CA) group:
Maurizio Biselli, Lorenzo Lani, Benedetta Stefanini, Valentina Santi, Alessandro Granito, Fabio Piscaglia, Francesco Tovoli, Luca Muratori, Francesca Benevento, Fabio Farinati, Gloria Allegrini, Calogero Cammà, Ciro Celsa, Paolo Giuffrida, Carmelo Marco Giacchetto, Gabriele Rancatore, Maria Vittoria Grassini, Roberta Ciccia, Alessandro Grova, Mauro Salvato, Valentina Adotti, Stefano Gitto, Fabio Marra, Martina Rosi, Vittoria Bevilacqua, Alberto Borghi, Fabio Conti, Anna Chiara Dall'Aglio, Giorgio Ercolani, Federica Mirici, Laura Schiadà, Chiara Scorzoni, Giulia Scandali, Francesca Romana Ponziani, Gabriele Missale, Andrea Olivani, Mario Capasso, Valentina Cossiga, Filomena Morisco, Ester Marina Cela, Antonio Facciorusso, Valentina Lauria, Giorgio Pelecca, Fabrizio Chegai, Fabio Coratella, Mariano Ortenzi, Serena Dell'Isola, Roberto Filomia, Concetta Pitrone, Giovanni Raimondo, Assunta Sauchella, Elton Dajti, Federico Ravaioli, Filippo Oliveri, Gabriele Ricco, Veronica Romagnoli, Alessandro Inno, Fabiana Marchetti, Pietro Coccoli, Antonio Malerba, Alberta Cappelli, Cristina Mosconi, Matteo Renzulli, Luca Marzi
|
|
| |
|
|
| |
| 37. | Blocking viral entry with bulevirtide reduces the number of HDV-infected hepatocytes in human liver biopsies |
| |
Hepatol. 2024 Jun;80(6):882-891. doi: 10.1016/j.jhep.2024.01.035.Epub 2024 Feb 8.
Lena Allweiss 1, Annika Volmari 2, Vithika Suri 3, Jeffrey J Wallin 3, John F Flaherty 3, Dmitry Manuilov 3, Bryan Downie 3, Marc Lütgehetmann 4, Jan-Hendrik Bockmann 1, Stephan Urban 5, Heiner Wedemeyer 6, Maura Dandri 7
|
|
| |
| 38. | A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and Delta cohort |
| |
Int J Infect Dis. 2024 May 25:107115. doi: 10.1016/j.ijid.2024.107115. Online ahead of print.
Loreta A Kondili 1, Giuseppina Brancaccio 2, Maria Elena Tosti 3, Barbara Coco 4, Maria Giovanna Quaranta 3, Vincenzo Messina 5, Alessia Ciancio 6, Filomena Morisco 7, Valentina Cossiga 7, Ernesto Claar 8, Valerio Rosato 8, Marianna Ciarallo 9, Irene Cacciola 10, Francesca Romana Ponziani 11, Lucia Cerrito 11, Roberta Coppola 12, Francesco Longobardi 12, Elisa Biliotti 13, Alessia Rianda 13, Francesco Barbaro 14, Nicola Coppola 15, Maria Stanzione 15, Francesco Barchiesi 16, Stefano Fagiuoli 17, Mauro Viganò 17, Marco Massari 18, Francesco Paolo Russo 19, Alberto Ferrarese 20, Diletta Laccabue 21, Vito Di Marco 22, Pierluigi Blanc 23, Aldo Marrone 24, Giulia Morsica 25, Alessandro Federico 26, Donatella Ieluzzi 27, Alba Rocco 28, Francesco Giuseppe Foschi 29, Alessandro Soria 30, Ivana Maida 31, Luchino Chessa 32, Michele Milella 33, Elena Rosselli Del Turco 34, Salvatore Madonia 35, Liliana Chemello 36, Ivan Gentile 37, Pierluigi Toniutto 38, Matteo Bassetti 39, Lorenzo Surace 40, Leonardo Baiocchi 41, Adriano Pellicelli 42, Adriano De Santis 43, Massimo Puoti 44, Elisabetta Degasperi 45, Grazia Anna Niro 46, Anna Linda Zignego 47, Antonio Craxi 48, Giovanni Raimondo 10, Teresa Antonia Santantonio 9, Maurizia Rossana Brunetto 49, Giovanni Battista Gaeta 50, On Behalf Of Piter Collaborating Investigators 50
|
|
| |
| 39. | Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase 3 randomized trial |
| |
J Hepatol. 2024 May 9:S0168-8278(24)00333-7. doi: 10.1016/j.jhep.2024.05.001.Online ahead of print.
Heiner Wedemeyer 1, Soo Aleman 2, Maurizia Brunetto 3, Antje Blank 4, Pietro Andreone 5, Pavel Bogomolov 6, Vladimir Chulanov 7, Nina Mamonova 7, Natalia Geyvandova 8, Viacheslav Morozov 9, Olga Sagalova 10, Tatyana Stepanova 11, Annemarie Berger 12, Sandra Ciesek 12, Dmitry Manuilov 13, Renee-Claude Mercier 13, Ben L Da 13, Grace M Chee 13, Mingyang Li 13, John F Flaherty 13, Audrey H Lau 13, Anu Osinusi 13, Julian Schulze Zur Wiesch 14, Markus Cornberg 15, Stefan Zeuzem 16, Pietro Lampertico 17
|
|
| |
|
|
| |
|
|
| |
| 42. | Safety and efficacy of off-label bulevirtide monotherapy in HDV patients with decompensated Child-B cirrhosis - a real world case series |
| |
Hepatology. 2024 Mar 13. doi: 10.1097/HEP.0000000000000847. Online ahead of print.
Christopher Dietz-Fricke 1, Elisabetta Degasperi 2, Mathias Jachs 3, Benjamin Maasoumy 1, Florian P Reiter 4, Andreas Geier 4, Julia M Grottenthaler 5, Christoph P Berg 5, Kathrin Sprinzl 6, Stefan Zeuzem 6, Juliana Gödiker 7, Bernhard Schlevogt 7 8, Toni Herta 9, Johannes Wiegand 9, Roberta Soffredini 2, Heiner Wedemeyer 1 10 11 12, Katja Deterding 1, Thomas Reiberger 3, Pietro Lampertico 2 13
|
|
| |
|
|
| |
| 44. | Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta |
| |
J Hepatol. 2024 Mar 11:S0168-8278(24)00156-9. doi: 10.1016/j.jhep.2024.03.005.Online ahead of print.
Mathias Jachs 1, Lisa Sandmann 2, Lukas Hartl 3, Tammo Tergast 4, Michael Schwarz 3, David Josef Maria Bauer 5, Lorenz Balcar 3, Alena Ehrenbauer 4, Benedikt Silvester Hofer 3, Markus Cornberg 6, Henrike Lenzen 4, Katja Deterding 4, Michael Trauner 7, Mattias Mandorfer 3, Heiner Wedemeyer 8, Thomas Reiberger 9, Benjamin Maasoumy 10
|
|
| |
|
|
| |
| 46. | An updated assessment of hepatitis delta prevalence among adults in Canada: A meta-analysis |
| |
J Viral Hepat. 2024 Apr 15. doi: 10.1111/jvh.13939. Online ahead of print.
Robert J Wong 1 2, Grishma Hirode 3, Jordan Feld 3, Steven S Wong 4, Carol Brosgart 5, Jeffrey Glenn 1 2, Saeed Hamid 6, Chari Cohen 7, Beatrice Zovich 7, John Ward 8, Heiner Wedemeyer 9, Cihan Yurdaydin 10, Robert Gish 7
|
|
| |
|
|
| |
|
|
| |
| 49. | Estimating the prevalence of hepatitis delta virus infection among adults in the United States: A meta-analysis |
| |
Liver Int. 2024 Apr 2. doi: 10.1111/liv.15921. Online ahead of print.
Robert J Wong 1 2, Carol Brosgart 3, Steven S Wong 4, Jordan Feld 5, Jeffrey Glenn 1 2, Saeed Hamid 6, Chari Cohen 7, Beatrice Zovich 7, John Ward 8, Heiner Wedemeyer 9, Cihan Yurdaydin 10, Robert Gish 7
|
|
| |
| 50. | Structure of antiviral drug bulevirtide bound to hepatitis B and D virus receptor protein NTCP |
| |
Nat Commun. 2024 Mar 20;15(1):2476. doi: 10.1038/s41467-024-46706-w.
Hongtao Liu 1, Dariusz Zakrzewicz 2, Kamil Nosol 1, Rossitza N Irobalieva 1, Somnath Mukherjee 3, Rose Bang-Sørensen 1, Nora Goldmann 4 5, Sebastian Kunz 2, Lorenzo Rossi 1, Anthony A Kossiakoff 6, Stephan Urban 7 8, Dieter Glebe 9 10, Joachim Geyer 11, Kaspar P Locher 12
|
|
| |
| 51. | Safety and efficacy of off-label bulevirtide monotherapy in HDV patients with decompensated Child-B cirrhosis - a real world case series |
| |
Hepatology. 2024 Mar 13. doi: 10.1097/HEP.0000000000000847. Online ahead of print.
Christopher Dietz-Fricke 1, Elisabetta Degasperi 2, Mathias Jachs 3, Benjamin Maasoumy 1, Florian P Reiter 4, Andreas Geier 4, Julia M Grottenthaler 5, Christoph P Berg 5, Kathrin Sprinzl 6, Stefan Zeuzem 6, Juliana Gödiker 7, Bernhard Schlevogt 7 8, Toni Herta 9, Johannes Wiegand 9, Roberta Soffredini 2, Heiner Wedemeyer 1 10 11 12, Katja Deterding 1, Thomas Reiberger 3, Pietro Lampertico 2 13
|
|
| |
|
|
| |
| 53. | Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta |
| |
J Hepatol. 2024 Mar 11:S0168-8278(24)00156-9. doi: 10.1016/j.jhep.2024.03.005.Online ahead of print.
Mathias Jachs 1, Lisa Sandmann 2, Lukas Hartl 3, Tammo Tergast 4, Michael Schwarz 3, David Josef Maria Bauer 5, Lorenz Balcar 3, Alena Ehrenbauer 4, Benedikt Silvester Hofer 3, Markus Cornberg 6, Henrike Lenzen 4, Katja Deterding 4, Michael Trauner 7, Mattias Mandorfer 3, Heiner Wedemeyer 8, Thomas Reiberger 9, Benjamin Maasoumy 10
|
|
| |
| 54. | Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories |
| |
J Hepatol. 2024 Feb;80(2):232-242. doi: 10.1016/j.jhep.2023.10.043.Epub 2023 Nov 27.
Collaborators
D Razavi-Shearer, H Child, K Razavi-Shearer, A Voeller, H Razavi, M Buti, F Tacke, N Terrault, S Zeuzem, Z Abbas, A Aghemo, U S Akarca, N Al Masri, A Alalwan, M Alanko Blomé, A Jerkeman, S Aleman, H Kamal, A Alghamdi, M Alghamdi, S Alghamdi, W Al-Hamoudi, E Ali, A Aljumah, I Altraif, J Amarsanaa, T Asselah, O Baatarkhuu, A Babameto, Z Ben-Ari, T Berg, M Biondi, W Braga, C Brandão-Mello, R Brown, M Brunetto, J Cabezas, M Cardoso, A Martins, H L Y Chan, H Cheinquer, C-J Chen, H-I Yang, P-J Chen, C-H Chien, W-L Chuang, L Cisneros Garza, B Coco, C Coffin, N Coppola, M Cornberg, A Craxi, J Crespo, L Cuko, V De Ledinghen, A-S Duberg, O Etzion, M L Ferraz, P Ferreira, X Forns, G Foster, J Fung, G Gaeta, J García-Samaniego, J Genov, L Gheorghe, P Gholam, R Gish, J Glenn, S Hamid, J Hercun, Y-C Hsu, C-C Hu, J-F Huang, R Idilman, W Jafri, N Janjua, D Jelev, J Jia, M Kåberg, K Kaita, J-H Kao, A Khan, D Y Kim, L Kondili, M Lagging, P Lampertico, P Lázaro, J V Lazarus, M-H Lee, H-I Yang, Y-S Lim, C Lobato, G Macedo, R Marinho, P Marotta, M C Mendes-Correa, N Méndez-Sánchez, M-C Navas, Q Ning, N Örmeci, M Orrego, C Osiowy, C Pan, M Pessoa, Z Piracha, C Pop, H Qureshi, G Raimondo, A Ramji, S Ribeiro, C Ríos-Hincapié, M Rodríguez, W Rosenberg, D Roulot, S Ryder, U Saeed, R Safadi, D Shouval, F Sanai, J F Sanchez-Avila, T Santantonio, C Sarrazin, W-K Seto, W-K Seto, M Simonova, J Tanaka, T Tergast, O Tsendsuren, C Valente, J M Villalobos-Salcedo, Y Waheed, G Wong, V Wong, T Yip, V Wong, J-C Wu, H-I Yang, M-L Yu, M-F Yuen, C Yurdaydin, E Zuckerman
|
|
| |
| 55. | Determinants of worse liver-related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort |
| |
Liver Int. 2023 Dec 15. doi: 10.1111/liv.15804. Online ahead of print.
Antonella d'Arminio Monforte 1, Alessandro Tavelli 1, Romina Salpini 2, Lorenzo Piermatteo 3, Stefano D'Anna 2, Stefania Carrara 4, Vincenzo Malagnino 5, Valentina Mazzotta 6, Giuseppina Brancaccio 7, Giulia Carla Marchetti 8, Elena Rosselli Del Turco 9, Roberto Rossotti 10, Cristina Mussini 11, Andrea Antinori 6, Sergio Lo Caputo 12, Francesca Ceccherini Silberstein 3, Giovanni Battista Gaeta 13, Valentina Svicher 3, Massimo Puoti 10; Icona Foundation Study Group
|
|
| |
| 56. | Liver stiffness measurement as a noninvasive method for the diagnosis of liver cirrhosis in patients with chronic hepatitis D virus infection |
| |
Aliment Pharmacol Ther. 2024 Jan 11. doi: 10.1111/apt.17878. Online ahead of print.
Lisa Sandmann 1 2, Elisabetta Degasperi 2 3 4, Kerstin Port 1, Soo Aleman 2 5 6, Jeffrey J Wallin 7, Dmitry Manuilov 7, Ben L Da 7, Markus Cornberg 1 2 8 9, Pietro Lampertico 2 3 4, Benjamin Maasoumy 1 8, Heiner Wedemeyer 1 2 8 10, Katja Deterding 1 10
|
|
| |
| 57. | Determinants of worse liver-related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort |
| |
Liver Int. 2023 Dec 15. doi: 10.1111/liv.15804. Online ahead of print.
Antonella d'Arminio Monforte 1, Alessandro Tavelli 1, Romina Salpini 2, Lorenzo Piermatteo 3, Stefano D'Anna 2, Stefania Carrara 4, Vincenzo Malagnino 5, Valentina Mazzotta 6, Giuseppina Brancaccio 7, Giulia Carla Marchetti 8, Elena Rosselli Del Turco 9, Roberto Rossotti 10, Cristina Mussini 11, Andrea Antinori 6, Sergio Lo Caputo 12, Francesca Ceccherini Silberstein 3, Giovanni Battista Gaeta 13, Valentina Svicher 3, Massimo Puoti 10; Icona Foundation Study Group
Collaborators
A d'Arminio Monforte, A Antinori, S Antinori, A Castagna, R Cauda, G Di Perri, E Girardi, R Iardino, A Lazzarin, G C Marchetti, C Mussini, E Quiros-Roldan, L Sarmati, B Suligoi, F von Schloesser, P Viale, A d'Arminio Monforte, A Antinori, A Castagna, F Ceccherini-Silberstein, A Cingolani, A Cozzi-Lepri, E Girardi, A Gori, S Lo Caputo, G Marchetti, F Maggiolo, C Mussini, M Puoti, C F Perno, A Antinori, F Bai, A Bandera, S Bonora, A Calcagno, D Canetti, A Castagna, F Ceccherini-Silberstein, A Cervo, S Cicalini, A Cingolani, P Cinque, A Cozzi-Lepri, A d'Arminio Monforte, A Di Biagio, R Gagliardini, A Giacomelli, E Girardi, N Gianotti, A Gori, G Guaraldi, S Lanini, G Lapadula, M Lichtner, A Lai, S Lo Caputo, G Madeddu, F Maggiolo, V Malagnino, G Marchetti, C Mussini, S Nozza, C F Perno, S Piconi, C Pinnetti, M Puoti, E Quiros Roldan, R Rossotti, S Rusconi, M M Santoro, A Saracino, L Sarmati, V Spagnuolo, N Squillace, V Svicher, L Taramasso, A Vergori, F Bovis, A Cozzi-Lepri, S De Benedittis, I Fanti, A Rodano', M Ponzano, A Tavelli, A Bove, M Cernuschi, L Cosmaro, < |
|
| |
| 58. | Hepatitis D: A Review |
| |
JAMA. 2023 Dec 26;330(24):2376-2387. doi: 10.1001/jama.2023.23242
Francesco Negro 1, Anna S Lok 2
|
|
| |
| 59. | Five-year follow-up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D |
| |
Liver Int. 2024 Jan;44(1):139-147. doi: 10.1111/liv.15745. Epub 2023 Oct 3.
Olympia E Anastasiou 1, Florin A Caruntu 2, Manuela G Curescu 3, Kendal Yalcin 4, Ulus S Akarca 5, Selim Gürel 6, Stefan Zeuzem 7, Andreas Erhardt 8 9, Stefan Lüth 10 11, George V Papatheodoridis 12, Onur Keskin 13, Kerstin Port 14, Monica Radu 2, Mustafa K Celen 4, Ramazan Idilman 13, Benjamin Heidrich 14, Ingmar Mederacke 14, Heiko von der Leyen 14 15, Julia Kahlhöfer 14 16 17, Maria von Karpowitz 14, Svenja Hardtke 16 18, Markus Cornberg 14 16 17 19, Cihan Yurdaydin 20, Heiner Wedemeyer 14 16 17 19
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 76. | Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppression |
| |
JHEP Rep. 2023 Apr 7;5(8):100751. doi: 10.1016/j.jhepr.2023.100751. eCollection 2023 Aug.
Mathias Jachs 1 2, Marlene Panzer 3, Lukas Hartl 1 2, Michael Schwarz 1 2, Lorenz Balcar 1 2, Jeremy V Camp 4, Petra Munda 1 2, Mattias Mandorfer 1 2, Michael Trauner 1 2, Stephan W Aberle 4, Heinz Zoller 3, Thomas Reiberger 1 2, Peter Ferenci 1
|
|
| |
| 77. | HDV RNA Assays: Performance characteristics, clinical utility and challenges |
| |
Hepatology. 2023 Aug 28. doi: 10.1097/HEP.0000000000000584. Online ahead of print.
Heiner Wedemeyer 1 2 3 4, Mitchell Leus 5, Thomas R Battersby 6, Jeffrey Glenn 7, Emmanuel Gordien 8, Saleem Kamili 9, Hema Kapoor 10, Harald H Kessler 11, Oliver Lenz 12, Marc Lütgehetmann 13 14, Tonya Mixson-Hayden 9, Christian O Simon 15, Michael Thomson 16, Gabriel Westman 17 18, Veronica Miller 5, Norah Terrault 19, Pietro Lampertico 20 21; HDV RNA Assays Writing Group at the HBV Forum
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 81. | HERACLIS-HDV cohort for the factors of underdiagnosis and prevalence of hepatitis D virus infection in HBsAg-positive patients |
| |
Liver Int. 2023 Sep;43(9):1879-1889. doi: 10.1111/liv.15638. Epub 2023 Jun 8.
George Papatheodoridis 1, Konstantinos Mimidis 2, Spilios Manolakopoulos 3, Christos Triantos 4, Ioannis Vlachogiannakos 1, Christos Veretanos 5, Melanie Deutsch 3, Stylianos Karatapanis 6, Ioannis Goulis 7, Ioannis Elefsiniotis 8, Evangelos Cholongitas 1, Vassilios Sevastianos 5, Dimitrios Christodoulou 9, Dimitrios Samonakis 10, Emanuel Manesis 11, Andreas Kapatais 12, Nikolaos Papadopoulos 3, Panagiota Ioannidou 1, Georgios Germanidis 13, George Giannoulis 14, Dimitra Lakiotaki 1, Dionysios Kogias 2, Ηarikleia Kranidioti 3, Konstantinos Zisimopoulos 4, Maria Mela 5, George Kontos 3, Paraskevi Fytili 1, Chrysanthi Manolaka 6, Polyxeni Agorastou 7, Spyridon I Pantzios 8, Margarita Papatheodoridi 1, Dimitrios Karagiannakis 1, Eleni Geladari 5, Nikolaos Psychos 9, Kalliopi Zachou 14, Anna Chalkidou 2, Anastasia Spanoudaki 3, Konstantinos Thomopoulos 4, George Dalekos 14
|
|
| |
|
|
| |
|
|
| |
| 84. | Hepatitis D virus infection: Pathophysiology, epidemiology and treatment. Report from the first international delta cure meeting 2022 |
| |
JHEP Rep. 2023 Jun 28;5(9):100818. doi: 10.1016/j.jhepr.2023.100818.eCollection 2023 Sep.
Pietro Lampertico 1 2, Elisabetta Degasperi 1, Lisa Sandmann 3 4 5, Heiner Wedemeyer 3 4 5; Delta Cure 2022 Working Group
Collaborators
- Delta Cure 2022 Working Group:
Cihan Yurdaydin, Dominique Roulot, Fabien Zoulim, Florin Alexandru Caruntu, Heiner Wedemeyer, Helenie Kefalakes, Julie Lucifora, Kosh Agarwal, Laurent Castera, Maria Buti, Mario Rizzetto, Markus Cornberg, Maura Dandri, Maurizia Brunetto, Nancy Reau, Robert Gish, Saeed Hamid, Soo Aleman, Stephan Urban, Tarik Asselah, Thomas Berg, Victor de Lédinghen
|
|
| |
| 85. | A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D |
| |
N Engl J Med. 2023 Jul 6;389(1):22-32. doi: 10.1056/NEJMoa2213429.Epub 2023 Jun 22.
Heiner Wedemeyer 1, Soo Aleman 1, Maurizia Rossana Brunetto 1, Antje Blank 1, Pietro Andreone 1, Pavel Bogomolov 1, Vladimir Chulanov 1, Nina Mamonova 1, Natalia Geyvandova 1, Viacheslav Morozov 1, Olga Sagalova 1, Tatyana Stepanova 1, Annemarie Berger 1, Dmitry Manuilov 1, Vithika Suri 1, Qi An 1, Ben Da 1, John Flaherty 1, Anu Osinusi 1, Yang Liu 1, Uta Merle 1, Julian Schulze Zur Wiesch 1, Stefan Zeuzem 1, Sandra Ciesek 1, Markus Cornberg 1, Pietro Lampertico 1; MYR 301 Study Group
Collaborators
MYR 301 Study Group:
Pavel Bogomolov, Natalya Geyvandova, Sergey Zotov, Olga Sagalova, Viacheslav Morozov, Tatjana Stepanova, Vladimir Chulanov, Stefan Zeuzem, Heiner Wedemeyer, Antje Blank, Julian Schulze-Zur-Wiesch, Katharina Willuweit, Maurizia Brunego, Pietro Lampertico, Pietro Andreone, Stephen Urban
|
|
| |
|
|
| |
|
|
| |
| 88. | Advancing research, awareness, screening, and linkage to care to eliminate HDV in the U.S |
| |
Hepatol Commun. 2023 Jun 22;7(7):e00168. doi: 10.1097/HC9.0000000000000168.eCollection 2023 Jul 1.
Megan Glynn 1, Chari Cohen 2, Robert G Gish 3, Richard Andrews 4, Amy Trang 5, Beatrice Zovich 2, Warren Hall 6, Ryan Clary 7, Joseph Balestreri 8, Lori Scott 8, Rachel Scott 8, Tamika Jackson 9, Boatemaa Ntiri-Reid 10, Alia Southworth 11, Douglas Dieterich 12, Thomas Sepe 13
|
|
| |
|
|
| |
| 90. | Quality-of-life scores improve after 96 weeks of PEG-IFNa-2a treatment of hepatitis D: An analysis of the HIDIT-II trial |
| |
Liver Int. 2023 Aug;43(8):1663-1676. doi: 10.1111/liv.15602.Epub 2023 May 15.
Katja Dinkelborg 1 2, Julia Kahlhöfer 1 3, Petra Dörge 1 3, Cihan Yurdaydin 4 5, Svenja Hardtke 3 6, Florin Alexandru Caruntu 7, Manuela G Curescu 8, Kendal Yalcin 9, Ulus S Akarca 10, Selim Gürel 11, Stefan Zeuzem 12, Andreas Erhardt 13, Stefan Lüth 6, George V Papatheodoridis 14, Onur Keskin 4, Kerstin Port 1, Monica Radu 7, Mustafa K Celen 9, Ramazan Idilman 4, Kristina Weber 15, Judith Stift 16, Ulrike Wittkop 17, Benjamin Heidrich 1 18 19, Ingmar Mederacke 1, Heiko von der Leyen 17, Hans Peter Dienes 16, Markus Cornberg 1 3 18 20, Armin Koch 15, Michael P Manns 1 18, Heiner Wedemeyer 1 18 19 21, Katja Deterding 1; HIDIT-2 Study Team
|
|
| |
| 91. | EASL Clinical Practice Guidelines on hepatitis delta virus |
| |
J Hepatol. 2023 Aug;79(2):433-460. doi: 10.1016/j.jhep.2023.05.001.Epub 2023 Jun 24.
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver
Collaborators
- Maurizia Rossana Brunetto, Gabriele Ricco, Francesco Negro, Heiner Wedemeyer, Cihan Yurdaydin, Tarik Asselah, George Papatheodoridis, Liana Gheorghe, Kosh Agarwal, Patrizia Farci, Maria Buti
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 96. | Farnesoid X receptor alpha ligands inhibit HDV in vitro replication and virion infectivity |
| |
Hepatol Commun. 2023 Apr 14;7(5):e0078. doi: 10.1097/HC9.0000000000000078.eCollection 2023 May 1.
Anne-Flore Legrand 1 2, Julie Lucifora 2 3, Benoît Lacombe 1, Camille Ménard 1, Maud Michelet 4, Adrien Foca 1, Pauline Abrial 1, Anna Salvetti 2, Michel Rivoire 5, Vincent Lotteau 1, David Durantel 2 3, Patrice André 1 2, Christophe Ramière 1 2 6
|
|
| |
|
|
| |
|
|
| |
| 99. | Hepatitis delta infection among persons living with HIV in Europe |
| |
Liver Int. 2023 Apr;43(4):819-828. doi: 10.1111/liv.15519. Epub 2023 Jan 21.
Charles Béguelin 1, Andrew Atkinson 1, Anders Boyd 2, Karolin Falconer 3, Nikolai Kirkby 4, Franziska Suter-Riniker 5, Huldrych F Günthard 6 7, Jürgen K Rockstroh 8, Amanda Mocroft 9 10, Andri Rauch 1, Lars Peters 10, Gilles Wandeler 1 11; for EuroSIDA and SHCS
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 103. | Strain-specific responsiveness of hepatitis D virus to interferon-alpha treatment |
| |
JHEP Rep. 2023 Jan 24;5(4):100673. doi: 10.1016/j.jhepr.2023.100673. eCollection 2023 Apr.
Katja Giersch 1, Paulina Perez-Gonzalez 1, Lennart Hendricks 1, Nora Goldmann 2, Jonathan Kolbe 1, Lennart Hermanussen 1, Jan-Hendrick Bockmann 1 3, Tassilo Volz 1, Annika Volmari 1, Lena Allweiss 1 3, Joerg Petersen 4, Dieter Glebe 2 3, Marc Lütgehetmann 3 5, Maura Dandri 1 3
|
|
| |
| 104. | No virologic resistance to bulevirtide monotherapy detected in patients through 24 weeks treatment in phase II and III clinical trials for chronic hepatitis delta |
| |
J Hepatol. 2023 Apr 27;S0168-8278(23)00313-6. doi: 10.1016/j.jhep.2023.04.027.Online ahead of print.
Julius Hollnberger 1, Yang Liu 2, Simin Xu 3, Silvia Chang 3, Ross Martin 3, Savrina Manhas 3, Thomas Aeschbacher 3, Bin Han 3, Tahmineh Yazdi 3, Lindsey May 3, Dong Han 3, Alex Shornikov 3, John Flaherty 3, Dmitry Manuilov 3, Vithika Suri 3, Tarik Asselah 4, Pietro Lampertico 5, Heiner Wedemeyer 6, Soo Aleman 7, Christopher Richards 3, Roberto Mateo 3, Evguenia Maiorova 3, Tomas Cihlar 3, Hongmei Mo 3, Stephan Urban 8
|
|
| |
| 105. | Silent HDV epidemics culminates in high levels of liver cirrhosis in endemic region despite 20 years of HBV vaccination |
| |
J Viral Hepat. 2023 Mar;30(3):182-194. doi: 10.1111/jvh.13783. Epub 2022 Dec 27.
Olga V Isaeva 1 2, Karen K Kyuregyan 1 2 3, Anastasia A Karlsen 1 2 3, Oleg V Kuzmin 2, Ilya A Potemkin 1 2, Vera S Kichatova 1 2, Fedor A Asadi Mobarkhan 2, Eugeniy V Mullin 2, Tatyana V Kozhanova 4 5, Victor A Manuylov 6, Andrey A Pochtovyy 6, Vladimir A Gushchin 6, Anna A Saryglar 7, Lyudmila Yu Ilchenko 2 4, Mikhail I Mikhailov 1 2
|
|
| |
|
|
| |
| 107. | Hepatitis B virus and hepatitis D virus infection in women with or at risk for HIV infection in the United States |
| |
Front Med (Lausanne). 2023 Mar 2;10:1070420. doi: 10.3389/fmed.2023.1070420.eCollection 2023.
Ilona Argirion 1, Parag Mahale 1, Ruth M Pfeiffer 2, Ping Liu 3, Adaora A Adimora 4, Matthew J Akiyama 5 6, Hector H Bolivar 7, Audrey French 8 9, Michael Plankey 10, Jennifer C Price 11, Aadia Rana 12, Anandi Sheth 13 14, Jill Koshiol 1, Eric C Seaberg 15, Mark H Kuniholm 16, Jeffrey Glenn 3, Thomas R O'Brien 1
|
|
| |
| 108. | Treating hepatitis D with bulevirtide - Real-world experience from 114 patients |
| |
JHEP Rep. 2023 Mar 15;5(4):100686. doi: 10.1016/j.jhepr.2023.100686. eCollection 2023 Apr.
Christopher Dietz-Fricke 1, Frank Tacke 2, Caroline Zöllner 2, Münevver Demir 2, Hartmut H Schmidt 3, Christoph Schramm 3, Katharina Willuweit 3, Christian M Lange 4, Sabine Weber 4, Gerald Denk 4, Christoph P Berg 5, Julia M Grottenthaler 5, Uta Merle 6, Alexander Olkus 6, Stefan Zeuzem 7, Kathrin Sprinzl 7, Thomas Berg 8, Florian van Bömmel 8, Johannes Wiegand 8, Toni Herta 8, Thomas Seufferlein 9, Eugen Zizer 9, Nektarios Dikopoulos 9, Robert Thimme 10, Christoph Neumann-Haefelin 10, Peter R Galle 11, Martin Sprinzl 11, Ansgar W Lohse 12, Julian Schulze Zur Wiesch 12 13, Jan Kempski 12 14, Andreas Geier 15, Florian P Reiter 15, Bernhard Schlevogt 16, Juliana Gödiker 16, Wolf Peter Hofmann 17, Peter Buggisch 18, Julia Kahlhöfer 1, Kerstin Port 1, Benjamin Maasoumy 1, Markus Cornberg 1 19 20, Heiner Wedemeyer 1 21 22 19, Katja Deterding 1
|
|
| |
|
|
| |
| 110. | Treatment of chronic hepatitis d with peginterferon lambda - the phase 2 LIMT-1 clinical trial |
| |
Hepatology. 2023 Feb 20. doi: 10.1097/HEP.0000000000000309. Online ahead of print.
Ohad Etzion 1 2, Saeed Hamid 3, Yoav Lurie 4, E J Gane 5, David Yardeni 1 2, Sarah Duehren 6, N Bader 3, Anat Nevo-Shor 1 2, S M Channa 7, S J Cotler 6, M Mawani 3, Om Parkash 3, Harel Dahari 6, Choong Ingrid 8, Jeffrey Glenn 9
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 114. | Hepatitis D virus interferes with hepatitis B virus RNA production via interferon-dependent and -independent mechanisms |
| |
J Hepatol. 2023 Jan 23;S0168-8278(23)00016-8. doi: 10.1016/j.jhep.2023.01.005.Online ahead of print.
Julie Lucifora 1, Dulce Alfaiate 2, Caroline Pons 3, Maud Michelet 4, Ricardo Ramirez 5, Floriane Fusil 6, Fouzia Amirache 6, Axel Rossi 7, Anne-Flore Legrand 6, Emilie Charles 6, Serena Vegna 4, Rayan Farhat 4, Michel Rivoire 8, Guillaume Passot 9, Nicolas Gadot 4, Barbara Testoni 4, Charlotte Bach 10, Thomas F Baumert 11, Anastasia Hyrina 5, Rudolf K Beran 5, Fabien Zoulim 12, Andre Boonstra 13, Hildegard Büning 7, Eloi R Verrier 10, François-Loïc Cosset 6, Simon P Fletcher 5, Anna Salvetti 6, David Durantel 3
|
|
| |
|
|
| |
| 116. | Bulevirtide monotherapy for 48 weeks in patients with HDV-related compensated cirrhosis and clinically significant portal hypertension |
| |
J Hepatol. 2022 Dec;77(6):1525-1531. doi: 10.1016/j.jhep.2022.07.016. Epub 2022 Aug 13.
Elisabetta Degasperi 1, Maria Paola Anolli 1, Sara Colonia Uceda Renteria 2, Dana Sambarino 1, Marta Borghi 1, Riccardo Perbellini 1, Caroline Scholtes 3, Floriana Facchetti 1, Alessandro Loglio 1, Sara Monico 1, Mirella Fraquelli 4, Andrea Costantino 4, Ferruccio Ceriotti 2, Fabien Zoulim 3, Pietro Lampertico 5
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 126. | Hepatitis D virus infection in a large cohort of immigrants in southern Italy: a multicenter, prospective study |
| |
Infection. 2022 Oct 12;1-8. doi: 10.1007/s15010-022-01938-0. Online ahead of print.
Pisaturo Mariantonietta 1 2, Alessio Loredana 1 3, Di Fraia Alessandra 1, Macera Margherita 1 4, Minichini Carmine 1, Cordua Emanuele 1, Onorato Lorenzo 1 5, Scotto Gaetano 6 7, Di Caprio Giovanni 2 8, Calò Federica 1 4, Sagnelli Caterina 1 5, Coppola Nicola 9
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 130. | Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial |
| |
Lancet Infect Dis. 2022 Sep 13;S1473-3099(22)00318-8. doi: 10.1016/S1473-3099(22)00318-8.Online ahead of print.
Heiner Wedemeyer 1, Katrin Schöneweis 2, Pavel Bogomolov 3, Antje Blank 4, Natalia Voronkova 5, Tatiana Stepanova 6, Olga Sagalova 7, Vladimir Chulanov 8, Marina Osipenko 9, Viacheslav Morozov 10, Natalia Geyvandova 11, Snezhana Sleptsova 12, Igor G Bakulin 13, Ilsiyar Khaertynova 14, Marina Rusanova 15, Anita Pathil 16, Uta Merle 17, Birgit Bremer 18, Lena Allweiss 19, Florian A Lempp 20, Kerstin Port 18, Mathias Haag 21, Matthias Schwab 22, Julian Schulze Zur Wiesch 19, Markus Cornberg 18, Walter E Haefeli 4, Maura Dandri 19, Alexander Alexandrov 23, Stephan Urban 24
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 134. | Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections |
| |
Gut. 2022 Aug 17;gutjnl-2022-327216. doi: 10.1136/gutjnl-2022-327216. Online ahead of print.
Rani Burm 1, Panagiota Maravelia 2, Gustaf Ahlen 2, Sandra Ciesek 3 4 5, Noelia Caro Perez 2, Anna Pasetto 2, Stephan Urban 6, Freya Van Houtte 1, Lieven Verhoye 1, Heiner Wedemeyer 7, Magnus Johansson 8, Lars Frelin 2, Matti Sällberg 9, Philip Meuleman 10
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 146. | Response-guided long-term treatment of chronic hepatitis D patients with bulevirtide-Results of A "real world" Study |
| |
Aliment Pharmacol Ther. 2022 May 5. doi: 10.1111/apt.16945. Online ahead of print.
Mathias Jachs 1 2, Caroline Schwarz 3, Marlene Panzer 4, Teresa Binter 1 2, Stephan W Aberle 5, Lukas Hartl 1 2, Kristina Dax 6, Elmar Aigner 7, Albert F Stättermayer 1 2, Petra Munda 1, Ivo Graziadei 8, Heidemarie Holzmann 5, Michael Trauner 1 2, Heinz Zoller 4, Michael Gschwantler 3, Mattias Mandorfer 1 2, Thomas Reiberger 1 2, Peter Ferenci 1
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 151. | Clinical Application of Droplet Digital PCR for Hepatitis Delta Virus Quantification |
| |
Biomedicines. 2022 Mar 29;10(4):792. doi: 10.3390/biomedicines10040792.
Antonella Olivero 1 2, Chiara Rosso 1, Alessia Ciancio 1 2, Maria Lorena Abate 1 2, Aurora Nicolosi 1, Giulia Troshina 1, Angelo Armandi 1, Davide Giuseppe Ribaldone 1 2, Giorgio Maria Saracco 1 2, Elisabetta Bugianesi 1 2, Mario Rizzetto 1, Gian Paolo Caviglia 1
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
| | | | | |
